Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Loving-kindness Meditation for Posttraumatic Stress Disorder (PTSD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01607632
Recruitment Status : Completed
First Posted : May 30, 2012
Last Update Posted : May 30, 2012
Sponsor:
Information provided by (Responsible Party):
David Kearney, Seattle Institute for Biomedical and Clinical Research

Brief Summary:
A before and after study of veterans who took part in a 12-week loving-kindness meditation course as an adjunct to their usual care for posttraumatic stress disorder.

Condition or disease Intervention/treatment Phase
Posttraumatic Stress Disorder Behavioral: loving-kindness meditation Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 42 participants
Allocation: N/A
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: An Open Pilot Study of Loving-Kindness Meditation for PTSD
Study Start Date : January 2010
Actual Primary Completion Date : June 2011
Actual Study Completion Date : June 2011

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: loving-kindness meditation Behavioral: loving-kindness meditation
A 12-week duration, 90 minute per session loving-kindness meditation course




Primary Outcome Measures :
  1. change in PTSD symptoms [ Time Frame: baseline, post-intervention, 3-month follow-up ]
    The PTSD symptom-scale interview was performed

  2. change in depressive symptoms [ Time Frame: baseline, post-intervention, 3-month follow-up ]
    The PROMIS measure for depression was administered



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • posttraumatic stress disorder

Exclusion Criteria:

  • psychosis
  • borderline personality disorder

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01607632


Locations
Layout table for location information
United States, Washington
VA Puget Sound
Seattle, Washington, United States, 98108
Sponsors and Collaborators
Seattle Institute for Biomedical and Clinical Research
Investigators
Layout table for investigator information
Principal Investigator: David Kearney, MD VA Puget Sound
Layout table for additonal information
Responsible Party: David Kearney, Staff Physician, Seattle Institute for Biomedical and Clinical Research
ClinicalTrials.gov Identifier: NCT01607632    
Other Study ID Numbers: 00173
First Posted: May 30, 2012    Key Record Dates
Last Update Posted: May 30, 2012
Last Verified: May 2012
Keywords provided by David Kearney, Seattle Institute for Biomedical and Clinical Research:
posttraumatic stress
depression
Additional relevant MeSH terms:
Layout table for MeSH terms
Stress Disorders, Traumatic
Stress Disorders, Post-Traumatic
Trauma and Stressor Related Disorders
Mental Disorders